Gondois-Rey Françoise, Dental Clélia, Halfon Philippe, Baumert Thomas F, Olive Daniel, Hirsch Ivan
Institut National de la Santé et de la Recherche MédicaleUMR891, Centre de Recherche en Cancérologie de Marseille, Marseille, France.
PLoS One. 2009;4(2):e4319. doi: 10.1371/journal.pone.0004319. Epub 2009 Feb 2.
Plasmacytoid dendritic cells (pDCs) are responsible for the production of type I IFN during viral infection. Viral elimination by IFN-alpha-based therapy in more than 50% of patients chronically infected with hepatitis C virus (HCV) suggests a possible impairment of production of endogenous IFN-alpha by pDCs in infected individuals. In this study, we investigated the impact of HCV on pDC function. We show that exposure of pDCs to patient serum- and cell culture-derived HCV resulted in production of IFN-alpha by pDCs isolated from some donors, although this production was significantly lower than that induced by influenza and human herpesvirus type 1 (HHV-1). Using specific inhibitors we demonstrate that endocytosis and endosomal acidification were required for IFN-alpha production by pDCs in response to cell culture-derived HCV. HCV and noninfectious HCV-like particles inhibited pDC-associated production of IFN-alpha stimulated with Toll-like receptor 9 (TLR9) agonists (CpG-A or HHV-1) but not that of IFN-alpha stimulated with TLR7 agonists (resiquimod or influenza virus). The blockade of TLR9-mediated production of IFN-alpha, effective only when pDCs were exposed to virus prior to or shortly after CpG-A stimulation, was already detectable at the IFN-alpha transcription level 2 h after stimulation with CpG-A and correlated with down-regulation of the transcription factor IRF7 expression and of TLR9 expression. In conclusion, rapidly and early occurring particle-host cell protein interaction during particle internalization and endocytosis followed by blockade of TLR9 function could result in less efficient sensing of HCV RNA by TLR7, with impaired production of IFN-alpha. This finding is important for our understanding of HCV-DC interaction and immunopathogenesis of HCV infection.
浆细胞样树突状细胞(pDCs)在病毒感染期间负责产生I型干扰素。基于干扰素-α的疗法可使超过50%的慢性丙型肝炎病毒(HCV)感染者清除病毒,这表明感染个体中pDCs产生内源性干扰素-α的能力可能受损。在本研究中,我们调查了HCV对pDC功能的影响。我们发现,将pDCs暴露于患者血清和细胞培养来源的HCV中,可使部分供体分离出的pDCs产生干扰素-α,尽管这种产生量明显低于流感病毒和人疱疹病毒1型(HHV-1)诱导的产生量。使用特异性抑制剂,我们证明内吞作用和内体酸化是pDCs响应细胞培养来源的HCV产生干扰素-α所必需的。HCV和非感染性HCV样颗粒抑制了Toll样受体9(TLR9)激动剂(CpG-A或HHV-1)刺激的pDC相关干扰素-α的产生,但不抑制TLR7激动剂(瑞喹莫德或流感病毒)刺激的干扰素-α的产生。TLR9介导的干扰素-α产生的阻断仅在pDCs在CpG-A刺激之前或之后不久暴露于病毒时有效,在CpG-A刺激后2小时即可在干扰素-α转录水平检测到,并且与转录因子IRF7表达和TLR9表达的下调相关。总之,在颗粒内化和内吞过程中快速且早期发生的颗粒-宿主细胞蛋白相互作用,随后TLR9功能被阻断,可能导致TLR7对HCV RNA的感应效率降低,干扰素-α产生受损。这一发现对于我们理解HCV与树突状细胞的相互作用以及HCV感染的免疫发病机制具有重要意义。